A share price of Vor Biopharma Inc [VOR] is currently trading at $14.53, up 7.39%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The VOR shares have gain 1.89% over the last week, with a monthly amount glided 73.80%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, JP Morgan started tracking the stock with Overweight rating on December 09, 2025, and set its price target to $43. Robert W. Baird upgraded its rating to an Outperform but stick to its price target of $64 on October 15, 2025. Stifel upgraded its rating to a Buy but $55 remained the price target by the analyst firm on September 24, 2025. H.C. Wainwright upgraded its rating to Buy for this stock on June 30, 2025, but kept the price target unchanged to $3. In a note dated July 26, 2022, Wedbush initiated an Outperform rating and provided a target price of $18 on this stock.
Vor Biopharma Inc experienced fluctuations in its stock price throughout the past year between $2.62 and $65.80. Currently, Wall Street analysts expect the stock to reach $52 within the next 12 months. Vor Biopharma Inc [NASDAQ: VOR] shares were valued at $14.53 at the most recent close of the market. An investor can expect a potential return of 257.88% based on the average VOR price forecast.
Analyzing the VOR fundamentals
Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at -99.56%, Pretax Profit Margin comes in at -664.56%, and Net Profit Margin reading is -664.56%. To continue investigating profitability, this company’s Return on Assets is posted at -13.9, Equity is 2.75 and Total Capital is -2.33. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.52 points at the first support level, and at 12.52 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.40, and for the 2nd resistance point, it is at 16.28.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Vor Biopharma Inc [NASDAQ:VOR] is 9.16. Further, the Quick Ratio stands at 9.16, while the Cash Ratio is 8.52.
Transactions by insiders
Recent insider trading involved RA CAPITAL MANAGEMENT, L.P., Director, that happened on Oct 29 ’25 when 0.25 million shares were sold. Director, RA CAPITAL MANAGEMENT, L.P. completed a deal on Oct 28 ’25 to sell 0.12 million shares. Meanwhile, Director RA CAPITAL MANAGEMENT, L.P. sold 24579.0 shares on Oct 30 ’25.
